CMS Issues “Coverage With Evidence Development” Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
CMS' "coverage with evidence development" (CED) draft guidance appears to venture into FDA's traditional jurisdiction of evaluating safety and effectiveness